Literature DB >> 29667486

LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.

Suzhen Song1, Weihua Yu2, Sen Lin2, Mingbao Zhang2, Teng Wang2, Shuang Guo2, Hongbo Wang2.   

Abstract

OBJECTIVE: This study was conducted to investigate the effects of ADP dependent glucokinase antisense RNA 1 (ADPGK-AS1)/ miR-205-5p/ zinc finger E-box binding homeobox 1 (ZEB1) on PC cells.
METHODS: Differentially expressed lncRNAs and miRNAs in pancreatic cancer (PC) were identified by microarray analysis. In silico ceRNA analysis was conducted to find out the interactions among lncRNAs, miRNAs and mRNAs. Quantitative real-time PCR (qRT-PCR) was utilized to examine the expression of miR-205-5p and lncRNA ADPGK-AS1 in PC and non-cancerous cells. The association between miR-205-5p and ADPGK-AS1 as well as miR-205-5p and ZEB1 was determined by dual-luciferase reporter gene assay. After manipulating the expression of ADPGK-AS1, mir-205-5p and ZEB1 in PANC-1 and SW-1990 cells, cell proliferation, migration, invasion and apoptosis were respectively confirmed by cell counting kit-8 (CCK-8) assay, transwell assay and TUNEL. Western blot was applied to examine the expression of Epithelial-mesenchymal Transition-related proteins. In vivo experiment was conducted to further determine the effect of miR-205-5p/ZEB1 on tumorigenic ability of PC cells.
RESULTS: MiR-205-5p was low-expressed while ZEB1 and ADPGK-AS1 were high-expressed in PC tissues and cells compared with the normal. Dual-luciferase reporter gene assay proved that ADPGK-AS1 could directly target miR-205-5p and miR-205-5p could directly target ZEB1 3'UTR. The expression of MiR-205-5p was negatively correlated with proliferation, migration and invasion, and positively correlated with apoptosis rate of PC cells, while ZEB1 and ADPGK-AS1 had an inversed effect. Further in vitro and in vivo investigation indicated that epithelial-mesenchymal transition (EMT) could be restrained by miR-205-5p through targeting ZEB1. ADPGK-AS1 strongly promoted the tumorigenesis via downregulating miR-205-5p expression and induced the EMT process in vivo.
CONCLUSION: ADPGK-AS1 inhibited miR-205-5p and therefore promoted PC progression through activating ZEB1-induced EMT.

Entities:  

Keywords:  ADPGK-AS1; EMT; ZEB1; miR-205-5p; pancreatic cancer

Mesh:

Substances:

Year:  2018        PMID: 29667486      PMCID: PMC5989801          DOI: 10.1080/15384047.2018.1423912

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  37 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.

Authors:  Liang Zhao; Hongwei Sun; Hongru Kong; Zongjing Chen; Bicheng Chen; Mengtao Zhou
Journal:  Cell Physiol Biochem       Date:  2017-08-15

3.  Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Authors:  Hiroshi Hirata; Yuji Hinoda; Varahram Shahryari; Guoren Deng; Koichi Nakajima; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer Res       Date:  2015-01-19       Impact factor: 12.701

4.  Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.

Authors:  J-Y Lee; M K Park; J-H Park; H J Lee; D H Shin; Y Kang; C H Lee; G Kong
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

Review 5.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

6.  Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer.

Authors:  Anupama Mittal; Deepak Chitkara; Stephan W Behrman; Ram I Mahato
Journal:  Biomaterials       Date:  2014-05-14       Impact factor: 12.479

7.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Cheuk-Wa Wong; Yan Wang; Wei-Mao Wang; Guo-Xin Hu; Li Zhang; Li-Jia Xiao; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  Oncotarget       Date:  2015-09-08

8.  miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2.

Authors:  Yosuke Harazono; Tomoki Muramatsu; Hironori Endo; Narikazu Uzawa; Tatsuyuki Kawano; Kiyoshi Harada; Johji Inazawa; Ken-ichi Kozaki
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

9.  Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis.

Authors:  Xiaodong Song; Guohong Cao; Lili Jing; Shengcui Lin; Xiaozhi Wang; Jinjin Zhang; Meirong Wang; Weili Liu; Changjun Lv
Journal:  J Cell Mol Med       Date:  2014-04-06       Impact factor: 5.310

10.  Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.

Authors:  Anna Torres; Joanna Kozak; Agnieszka Korolczuk; Dominika Rycak; Paulina Wdowiak; Ryszard Maciejewski; Kamil Torres
Journal:  Oncotarget       Date:  2016-11-08
View more
  10 in total

1.  Long non-coding RNA SNHG1 promotes Cyclin D1-mediated proliferation in pancreatic cancer by acting as a ceRNA of miR-195.

Authors:  Dong Li; Xuming Zhang; Yuxi Yang; Yi Shen; Qibing Zhang; Hong Liu; Xiaofeng Li; Chunqiu Zhang; Pengyu Liu; Xiangzheng Qin
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

Review 2.  Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer.

Authors:  Xiaoying Yang; Cheng Qin; Bangbo Zhao; Tianhao Li; Yuanyang Wang; Zeru Li; Tianyu Li; Weibin Wang
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

3.  The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer.

Authors:  Xiao-Yu Li; Li-Ye Zhou; Hao Luo; Qi Zhu; Liang Zuo; Gu-Yue Liu; Chu Feng; Jun-Yong Zhao; Yuan-Yuan Zhang; Xue Li
Journal:  Aging (Albany NY)       Date:  2019-08-10       Impact factor: 5.682

4.  Long Non-coding RNA MIAT Knockdown Prevents the Formation of Intracranial Aneurysm by Downregulating ENC1 via MYC.

Authors:  Xinguo Li; Hang Zhao; Jihui Liu; Jing Tong
Journal:  Front Physiol       Date:  2021-01-21       Impact factor: 4.566

Review 5.  Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer.

Authors:  Seung Wan Son; Mun Gyu Song; Ba Da Yun; Jong Kook Park
Journal:  Biomedicines       Date:  2021-03-07

Review 6.  Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer.

Authors:  Sergey Parfenyev; Aastha Singh; Olga Fedorova; Alexandra Daks; Ritu Kulshreshtha; Niсkolai A Barlev
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

7.  Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma.

Authors:  Hongpan Zhang; Meihan Liu; Zhihao Yang; Guobo Du; Bin Yu; Yan Gui; Lu Cao; Xianfu Li; Bangxian Tan
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

Review 8.  Long noncoding RNAs: role and contribution in pancreatic cancer.

Authors:  K T Ramya Devi; Dharshene Karthik; TharunSelvam Mahendran; M K Jaganathan; Sanjana Prakash Hemdev
Journal:  Transcription       Date:  2021-05-26

9.  LncRNA ZEB1-AS1 Regulates Colorectal Cancer Cells by MiR-205/YAP1 Axis.

Authors:  Zhong Jin; Bing Chen
Journal:  Open Med (Wars)       Date:  2020-03-08

Review 10.  Oncogenic Role of Exosomal Circular and Long Noncoding RNAs in Gastrointestinal Cancers.

Authors:  Ba Da Yun; Ye Ji Choi; Seung Wan Son; Gabriel Adelman Cipolla; Fernanda Costa Brandão Berti; Danielle Malheiros; Tae-Jin Oh; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.